Wijngaard, Peter

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

Journal Article

Chandrasekhar, Jaya; Sartori, Samantha; Mehran, Roxana; Aquino, Melissa; Vogel, Birgit; Asgar, Anita W; Webb, John G; Tchetche, Didier; Dumonteil, Nicolas; Colombo, Antonio; Windecker, Stephan; Claessen, Bimmer E; Ten Berg, Jurriën M; Hildick-Smith, David; Wijngaard, Peter; Lefèvre, Thierry; Deliargyris, Efthymios N; Hengstenberg, Christian; Anthopoulos, Prodromos and Dangas, George D (2021). Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial. Clinical research in cardiology, 110(5), pp. 649-657. Springer-Verlag 10.1007/s00392-020-01787-7

Power, David; Schäfer, Ulrich; Guedeney, Paul; Claessen, Bimmer E; Sartori, Samantha; Sorrentino, Sabato; Lefèvre, Thierry; Kupatt, Christian; Tchetche, Didier; Dumonteil, Nicolas; Webb, John G; Colombo, Antonio; Windecker, Stephan; Ten Berg, Jurriën M; Hildick-Smith, David; Boekstegers, Peter; Linke, Axel; Tron, Christophe; Van Belle, Eric; Asgar, Anita W; ... (2019). Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial. Catheterization and cardiovascular interventions, 93(7), pp. 1374-1381. Wiley-Blackwell 10.1002/ccd.28295

Dangas, George D; Lefèvre, Thierry; Kupatt, Christian; Tchetche, Didier; Schäfer, Ulrich; Dumonteil, Nicolas; Webb, John G; Colombo, Antonio; Windecker, Stephan; Ten Berg, Jurriën M; Hildick-Smith, David; Mehran, Roxana; Boekstegers, Peter; Linke, Axel; Tron, Christophe; Van Belle, Eric; Asgar, Anita W; Fach, Andreas; Jeger, Raban; Sardella, Gennaro; ... (2015). Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. Journal of the American College of Cardiology, 66(25), pp. 2860-2868. Elsevier 10.1016/j.jacc.2015.10.003

This list was generated on Mon Dec 30 18:22:31 2024 CET.
Provide Feedback